Gary T. Ferguson
- Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE studyBy Eric D. Bateman, Gary T. Ferguson, Neil Barnes, Nicola Gallagher, Yulia Green, Michelle Henley and Donald BanerjiEric D. Bateman1Dept of Medicine, University of Cape Town, Cape Town, South AfricaGary T. Ferguson2Pulmonary Research Institute of Southeast Michigan, Livonia, MINeil Barnes3London Chest Hospital, Barts Health NHS Trust, LondonNicola Gallagher4Novartis Horsham Research Centre, Horsham, UKYulia Green4Novartis Horsham Research Centre, Horsham, UKMichelle Henley4Novartis Horsham Research Centre, Horsham, UKDonald Banerji5Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
- Benefits of dual bronchodilation with QVA149 once daily versus placebo, indacaterol, NVA237 and tiotropium in patients with COPD: The SHINE studyBy Eric Bateman, Gary T. Ferguson, Neil Barnes, Nicola Gallagher, Yulia Green, Rachael Horton, Michelle Henley and Donald BanerjiEric Bateman1Department of Medicine, University of Cape Town, South AfricaGary T. Ferguson2Pulmonary Department, Pulmonary Research Institute of Southeast Michigan, Livonia, MI, United StatesNeil Barnes3London Chest Hospital, Barts Health NHS Trust, London, United KingdomNicola Gallagher4Respiratory Department, Novartis Horsham Resarch Centre, Horsham, United KingdomYulia Green4Respiratory Department, Novartis Horsham Resarch Centre, Horsham, United KingdomRachael Horton4Respiratory Department, Novartis Horsham Resarch Centre, Horsham, United KingdomMichelle Henley4Respiratory Department, Novartis Horsham Resarch Centre, Horsham, United KingdomDonald Banerji5Respiratory Department, Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States
- Cardio- and cerebro-vascular safety of QVA149: Results from a pooled analysisBy Gary T. Ferguson, Neil Barnes, Rajendra Mehta, Peter D'Andrea, Hungta Chen and Donald BanerjiGary T. Ferguson1Pulmonology, Pulmonary Research Institute of Southeast Michigan, Livonia, United StatesNeil Barnes2Department of Respiratory Medicine, London Chest Hospital, Barts Health NHS Trust, London, United KingdomRajendra Mehta3Allergy and Asthma Care, Allergy & Asthma Care and Research Centre, Indore, IndiaPeter D'Andrea4Primary Care, Novartis Pharmaceuticals Corporation, East Hanover, United StatesHungta Chen4Primary Care, Novartis Pharmaceuticals Corporation, East Hanover, United StatesDonald Banerji4Primary Care, Novartis Pharmaceuticals Corporation, East Hanover, United States
- Effect of tiotropium on spontaneous expiratory flow-volume curves during exercise in GOLD 1&2 COPDBy Janos Porszasz, Shuyi Ma, Robert Cao, Ashwani Gore, William Phillips, Rachel Cooper, François Maltais, Gary T. Ferguson, Denis E. O'Donnell, Heather Paden and Richard CasaburiJanos Porszasz1Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United StatesShuyi Ma2Department of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, IL, United StatesRobert Cao1Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United StatesAshwani Gore1Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United StatesWilliam Phillips1Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United StatesRachel Cooper1Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United StatesFrançois Maltais3Centre De Recherche, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Université Laval, Québec, CanadaGary T. Ferguson4Pulmonary Research, Pulmonary Research Institute of Southeast Michigan, Livonia, MI, United StatesDenis E. O'Donnell5Department of Medicine, Queen's University & Kingston General Hospital, Kingston, ON, CanadaHeather Paden6Clinical Trial Management, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, United StatesRichard Casaburi1Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United States
- An official American Thoracic Society/European Respiratory Society statement: research questions in COPDBy Bartolome R. Celli, Marc Decramer, Jadwiga A. Wedzicha, Kevin C. Wilson, Alvar Agustí, Gerard J. Criner, William MacNee, Barry J. Make, Stephen I. Rennard, Robert A. Stockley, Claus Vogelmeier, Antonio Anzueto, David H. Au, Peter J. Barnes, Pierre-Regis Burgel, Peter M. Calverley, Ciro Casanova, Enrico M. Clini, Christopher B. Cooper, Harvey O. Coxson, Daniel J. Dusser, Leonardo M. Fabbri, Bonnie Fahy, Gary T. Ferguson, Andrew Fisher, Monica J. Fletcher, Maurice Hayot, John R. Hurst, Paul W. Jones, Donald A. Mahler, François Maltais, David M. Mannino, Fernando J. Martinez, Marc Miravitlles, Paula M. Meek, Alberto Papi, Klaus F. Rabe, Nicolas Roche, Frank C. Sciurba, Sanjay Sethi, Nikos Siafakas, Don D. Sin, Joan B. Soriano, James K. Stoller, Donald P. Tashkin, Thierry Troosters, Geert M. Verleden, Johny Verschakelen, Jorgen Vestbo, John W. Walsh, George R. Washko, Robert A. Wise, Emiel F.M. Wouters and Richard L. ZuWallackBartolome R. CelliFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMarc DecramerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJadwiga A. WedzichaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsKevin C. WilsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAlvar AgustíFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGerard J. CrinerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsWilliam MacNeeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsBarry J. MakeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsStephen I. RennardFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsRobert A. StockleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsClaus VogelmeierFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAntonio AnzuetoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDavid H. AuFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPeter J. BarnesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPierre-Regis BurgelFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPeter M. CalverleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsCiro CasanovaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsEnrico M. CliniFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsChristopher B. CooperFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsHarvey O. CoxsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDaniel J. DusserFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsLeonardo M. FabbriFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsBonnie FahyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGary T. FergusonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAndrew FisherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMonica J. FletcherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMaurice HayotFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJohn R. HurstFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPaul W. JonesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDonald A. MahlerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsFrançois MaltaisFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDavid M. ManninoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsFernando J. MartinezFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsMarc MiravitllesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsPaula M. MeekFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsAlberto PapiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsKlaus F. RabeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsNicolas RocheFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsFrank C. SciurbaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsSanjay SethiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsNikos SiafakasFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDon D. SinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJoan B. SorianoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJames K. StollerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsDonald P. TashkinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsThierry TroostersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGeert M. VerledenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJohny VerschakelenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJorgen VestboFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsJohn W. WalshFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsGeorge R. WashkoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsRobert A. WiseFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsEmiel F.M. WoutersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authorsRichard L. ZuWallackFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. 1Project co-chairs; should be considered co-first authors
- An official American Thoracic Society/European Respiratory Society statement: research questions in COPDBy Bartolome R. Celli, Marc Decramer, Jadwiga A. Wedzicha, Kevin C. Wilson, Alvar A. Agustí, Gerard J. Criner, William MacNee, Barry J. Make, Stephen I. Rennard, Robert A. Stockley, Claus Vogelmeier, Antonio Anzueto, David H. Au, Peter J. Barnes, Pierre-Regis Burgel, Peter M. Calverley, Ciro Casanova, Enrico M. Clini, Christopher B. Cooper, Harvey O. Coxson, Daniel J. Dusser, Leonardo M. Fabbri, Bonnie Fahy, Gary T. Ferguson, Andrew Fisher, Monica J. Fletcher, Maurice Hayot, John R. Hurst, Paul W. Jones, Donald A. Mahler, François Maltais, David M. Mannino, Fernando J. Martinez, Marc Miravitlles, Paula M. Meek, Alberto Papi, Klaus F. Rabe, Nicolas Roche, Frank C. Sciurba, Sanjay Sethi, Nikos Siafakas, Don D. Sin, Joan B. Soriano, James K. Stoller, Donald P. Tashkin, Thierry Troosters, Geert M. Verleden, Johny Verschakelen, Jorgen Vestbo, John W. Walsh, George R. Washko, Robert A. Wise, Emiel F.M. Wouters and Richard L. ZuWallackBartolome R. CelliFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMarc DecramerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJadwiga A. WedzichaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionKevin C. WilsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAlvar A. AgustíFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGerard J. CrinerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionWilliam MacNeeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionBarry J. MakeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionStephen I. RennardFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionRobert A. StockleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionClaus VogelmeierFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAntonio AnzuetoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDavid H. AuFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPeter J. BarnesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPierre-Regis BurgelFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPeter M. CalverleyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionCiro CasanovaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionEnrico M. CliniFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionChristopher B. CooperFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionHarvey O. CoxsonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDaniel J. DusserFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionLeonardo M. FabbriFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionBonnie FahyFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGary T. FergusonFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAndrew FisherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMonica J. FletcherFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMaurice HayotFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJohn R. HurstFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPaul W. JonesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDonald A. MahlerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionFrançois MaltaisFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDavid M. ManninoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionFernando J. MartinezFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionMarc MiravitllesFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionPaula M. MeekFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionAlberto PapiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionKlaus F. RabeFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionNicolas RocheFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionFrank C. SciurbaFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionSanjay SethiFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionNikos SiafakasFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDon D. SinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJoan B. SorianoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJames K. StollerFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionDonald P. TashkinFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionThierry TroostersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGeert M. VerledenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJohny VerschakelenFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJorgen VestboFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionJohn W. WalshFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionGeorge R. WashkoFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionRobert A. WiseFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionEmiel F.M. WoutersFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements sectionRichard L. ZuWallackFurther details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section
- Tiotropium + olodaterol fixed-dose combination shows clinically meaningful improvements in quality of life versus placeboBy Dave Singh, Gary T. Ferguson, Josef Bolitschek, Lars Grönke, Christoph Hallmann, Nathan Bennett, Roger Abrahams, Olaf Schmidt and Leif BjermerDave Singh1The Medicines Evaluation Unit (MEU), University Hospital of South Manchester, Manchester, United KingdomGary T. Ferguson2Pulmonary Research, Institute of Southeast Michigan, Livonia, United StatesJosef Bolitschek3Department of Pneumology, Krankenhaus der Elisabethinen, Linz, AustriaLars Grönke4Medical Affairs Department, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyChristoph Hallmann4Medical Affairs Department, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyNathan Bennett5Statistics Department, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, United StatesRoger Abrahams6Department of Clinical Research, Morgantown Pulmonary Associates, Morgantown, United StatesOlaf Schmidt7Lungen- und Bronchialheilkunde, KPPK Studienzentrum, Koblenz, GermanyLeif Bjermer8Department of Respiratory Medicine and Allergology, Lund University, Lund, Sweden
- LATE-BREAKING ABSTRACT: PT003, a novel co-suspension MDI glycopyrronium/formoterol fixed-dose combination is superior to monocomponents in patients with COPDBy Klaus Rabe, Fernando Martinez, Roberto Rodriguez-Roisin, Leonardo M. Fabbri, Gary T. Ferguson, Paul Jones, Stephen Rennard, Michael Golden, Patrick Darken, Chad Orevillo, Tracy Fischer and Colin ReisnerKlaus Rabe1Lungen Clinic Grosshansdorf, Airway Research Center North, Member of the German Center for Lung Research (DZL), Grosshansdorf, GermanyFernando Martinez2Department of Internal Medicine, Weill Cornell Medical College, New York, NY United StatesRoberto Rodriguez-Roisin3Servei de Pneumologia, Institut del Tòrax, Hospital Clinic-IDIBAPS-CIBERES, Barcelona, SpainLeonardo M. Fabbri4Department of Oncology, Haematology and Respiratory Diseases, University of Modena, Modena, ItalyGary T. Ferguson5COPD, Pulmonary Research Institute of Southeast Michigan, Livonia, MI United StatesPaul Jones6Institute for Infection and Immunity, St. George's, University of London, London, United KingdomStephen Rennard7Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha, NE United StatesMichael Golden8Clinical Development and Medical Affairs, Pearl Therapeutics Inc., Morristown, NJ United StatesPatrick Darken8Clinical Development and Medical Affairs, Pearl Therapeutics Inc., Morristown, NJ United StatesChad Orevillo8Clinical Development and Medical Affairs, Pearl Therapeutics Inc., Morristown, NJ United StatesTracy Fischer8Clinical Development and Medical Affairs, Pearl Therapeutics Inc., Morristown, NJ United StatesColin Reisner8Clinical Development and Medical Affairs, Pearl Therapeutics Inc., Morristown, NJ United States
- The fixed-dose combination of tiotropium + olodaterol has a rapid onset of action in patients with COPDBy Gary T. Ferguson, Emilio Pizzichini, Matjaz Flezar, Lars Grönke and Lawrence KorduckiGary T. Ferguson1Pulmonary Research, Institute of Southeast Michigan, Livonia, MI United StatesEmilio Pizzichini2NUPAIVA (Asthma Research Centre), Universidade Federal de Santa Catarina, Santa Catarina, BrazilMatjaz Flezar3University Clinic for Respiratory and Allergic Diseases, Klinika Golnik, Golnik, SloveniaLars Grönke4Medical Affairs Department, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyLawrence Korducki5Statistics Department, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.